Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Equity Ratio: 2009-2025

Historic Equity Ratio for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Sep 2025 value amounting to 0.40.

  • Cumberland Pharmaceuticals' Equity Ratio rose 22.76% to 0.40 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.40, marking a year-over-year increase of 22.76%. This contributed to the annual value of 0.30 for FY2024, which is 16.48% down from last year.
  • Latest data reveals that Cumberland Pharmaceuticals reported Equity Ratio of 0.40 as of Q3 2025, which was down 3.84% from 0.41 recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Equity Ratio ranged from a high of 0.54 in Q2 2021 and a low of 0.30 during Q4 2024.
  • Moreover, its 3-year median value for Equity Ratio was 0.40 (2025), whereas its average is 0.37.
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Equity Ratio fell by 23.01% in 2022, and later rose by 22.83% in 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Equity Ratio (Quarterly) stood at 0.51 in 2021, then decreased by 23.01% to 0.39 in 2022, then fell by 7.24% to 0.36 in 2023, then declined by 16.48% to 0.30 in 2024, then increased by 22.76% to 0.40 in 2025.
  • Its Equity Ratio was 0.40 in Q3 2025, compared to 0.41 in Q2 2025 and 0.41 in Q1 2025.